KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $1.7 billion.

  • Gilead Sciences' Other Operating Expenses fell 5458.34% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 billion, marking a year-over-year decrease of 5719.28%. This contributed to the annual value of $15.1 billion for FY2024, which is 9594.96% up from last year.
  • Per Gilead Sciences' latest filing, its Other Operating Expenses stood at $1.7 billion for Q3 2025, which was down 5458.34% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Other Operating Expenses registered a high of $8.1 billion during Q1 2024, and its lowest value of $1.3 billion during Q3 2021.
  • Over the past 5 years, Gilead Sciences' median Other Operating Expenses value was $1.8 billion (recorded in 2025), while the average stood at $2.4 billion.
  • Per our database at Business Quant, Gilead Sciences' Other Operating Expenses soared by 33131.31% in 2024 and then crashed by 7789.97% in 2025.
  • Quarter analysis of 5 years shows Gilead Sciences' Other Operating Expenses stood at $3.3 billion in 2021, then crashed by 52.85% to $1.6 billion in 2022, then soared by 59.97% to $2.5 billion in 2023, then crashed by 36.89% to $1.6 billion in 2024, then grew by 10.83% to $1.7 billion in 2025.
  • Its last three reported values are $1.7 billion in Q3 2025, $1.8 billion for Q2 2025, and $1.8 billion during Q1 2025.